(Q5969732)

Icrf 193 (English)

9 October 2016

C₁₂H₁₈N₄O₄

1 reference

Icrf 193 (English)

9 October 2016

CC(C(C)N1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2

1 reference

Icrf 193 (English)

9 October 2016

C[C@H]([C@H](C)N1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2

0 references

subject has role

antineoplastic

1 reference

Medical Subject Headings

MeSH descriptor ID

C070899

topoisomerase II inhibitor

15 March 2018

1 reference

Medical Subject Headings

MeSH descriptor ID

C070899

InChI=1S/C12H18N4O4/c1-7(15-3-9(17)13-10(18)4-15)8(2)16-5-11(19)14-12(20)6-16/h7-8H,3-6H2,1-2H3,(H,13,17,18)(H,14,19,20)/t7-,8+

15 March 2018

Identifiers

InChI

0 references

InChIKey

OBYGAPWKTPDTAS-OCAPTIKFSA-N

1 reference

imported from Wikimedia project

ChEBI release 2020-09-01

CAS Registry Number

21416-68-2

1 reference

1 reference

English

title

4,4'-(2,3-Butanediyl)di(2,6-piperazinedione) (English)

matched by identifier from

9 October 2016

PubChem CID

119081

1 reference

InChIKey

OBYGAPWKTPDTAS-OCAPTIKFSA-N

ChEBI ID

93771

mapping relation type

2 references

English

title

4-[3-(3,5-dioxo-1-piperazinyl)butan-2-yl]piperazine-2,6-dione (English)

matched by identifier from

9 October 2016

International Chemical Identifier

InChI

InChI=1S/C12H18N4O4/c1-7(15-3-9(17)13-10(18)4-15)8(2)16-5-11(19)14-12(20)6-16/h7-8H,3-6H2,1-2H3,(H,13,17,18)(H,14,19,20)/t7-,8+

1 reference

matched by identifier from

ICRF-193 (English)

9 October 2016

1 reference

0 references

1 reference

InChIKey

OBYGAPWKTPDTAS-OCAPTIKFSA-N

DSSTOX compound identifier

0 references

1 reference

Medical Subject Headings

14 March 2018

1 reference

28 October 2013

Microsoft Academic ID

0 references

1 reference

inferred by common MeSH mappings on source and on Wikidata

UMLS 2023